Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
作者信息
Sedwick W D, Fyfe M J, Brown O E, Frazer T A, Kutler M, Laszlo J
出版信息
Mol Pharmacol. 1979 Sep;16(2):607-13.
PMID:514260
Abstract
摘要
相似文献
1
Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
Mol Pharmacol. 1979 Sep;16(2):607-13.
2
New dose-time relationships of folate antagonists to sustain inhibition of human lymphoblasts and leukemic cells in vitro.
Cancer Res. 1979 Sep;39(9):3612-8.
3
Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
Mol Pharmacol. 1981 Nov;20(3):637-43.
4
Comparative studies of methotrexate and metoprine: metabolic toxicity and cell killing.
Adv Enzyme Regul. 1978;17:399-416. doi: 10.1016/0065-2571(79)90024-4.
5
Human plasma and amino acids as moderators of uptake and metabolic consequences of antifolates in WIL-2 and human leukemia cells.人血浆和氨基酸作为抗叶酸药物在WIL-2细胞和人白血病细胞中摄取及代谢结果的调节剂。
J Natl Cancer Inst. 1981 Mar;66(3):445-51.
6
An antifolate-induced lesion in newly synthesized DNA.
Adv Enzyme Regul. 1980;19:295-308. doi: 10.1016/0065-2571(81)90021-2.
7
The intracellular mechanism of action of metoprine (DDMP).
Eur J Cancer (1965). 1980 Dec;16(12):1547-54. doi: 10.1016/0014-2964(80)90027-4.
8
9
10
Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.
Cancer Res. 1985 Mar;45(3):978-82.
引用本文的文献
1
Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.通过中位效应分析评估依达曲沙和顺铂联合使用对A549肺癌细胞系的时间依赖性协同作用。
Cancer Chemother Pharmacol. 1993;33(3):245-50. doi: 10.1007/BF00686223.
2
Biological and biochemical properties of new anticancer folate antagonists.新型抗癌叶酸拮抗剂的生物学和生物化学特性
Cancer Metastasis Rev. 1987;5(3):251-70. doi: 10.1007/BF00047000.
Zotero 插件